1. |
England MJ, Liverman CT, Schultz AM, et al. Epilepsy across the spectrum: promoting health and understanding. a summary of the institute of medicine report.. Epilepsy Behav, 2012, 25(2): 266-276.
|
2. |
Taylor J, Baker GA. Newly diagnosed epilepsy: Cognitive outcome at 5 years. Epilepsy Behav, 2010, 18(4) : 397-403.
|
3. |
Helmstaedter C, Witt JA. Clinical neuropsychology in epilepsy: theoretical and practical issues. Handb Clin Neurol, 2012, 107: 437-459.
|
4. |
Bootsma HP, Vos AM, Hulsman J, et al. Lamotrigine in clinical practice: Long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy Behav, 2008, 12(2): 262-268.
|
5. |
IJff DM, van Veenendaal TM, Majoie HJ, et al. Cognitive effects of lacosamide as adjunctive therapy in refractory epilepsy. Acta Neurol Scand, 2015, 131(6): 347-354.
|
6. |
Tzitiridou M, Panou T, Ramantani G, et al. Oxcarbazepine monotherapy in benign childhood epilepsy with centrotemporal spikes: a clinical and cognitive evaluation. Epilepsy Behav, 2005, 7(3): 458-467.
|
7. |
Donati F, Gobbi G, Campistol J, et al. The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Seizure, 2007, 16(8): 670-679.
|
8. |
Sun W, Wang Y, Wang W, et al. Attention changes in epilepsy patients following 3-month topiramate or valproate treatment revealed by event-related potential. Int J Psychophysiol, 2008, 68(3): 235-241.
|
9. |
Jellett AP, Jenks K, Lucas M, et al. Standard dose Valproic acid does not cause additional cognitive impact in a rodent model of intractable epilepsy. Epilepsy Res, 2015, 110: 88-94.
|
10. |
中国抗癫痫协会. 临床诊疗指南癫痫病分册 (2015 修订版). 北京: 人民卫生出版社. 2015: 15-19.
|
11. |
Rathouz PJ, Zhao Q, Jones JE, et al. Cognitive development in children with new onset epilepsy. Dev Med Child Neurol, 2014, 56(7): 635-641.
|
12. |
Kellermann TS, Bonilha L, Lin JJ. Mapping the landscape of cognitive development in children with epilepsy. Cortex, 2015, 66: 1-8.
|
13. |
Witt JA, Helmstaedter C. Should cognition be screened in new-onset epilepsies? A study in 247 untreated patients. J Neurol, 2012, 259(8): 1727-1731.
|
14. |
Witt JA, Werhahn KJ, Kramer G, et al. Cognitivebehavioral screening in elderly patients with new-onset epilepsy before treatment. Acta Neurol Scand, 2014, 130 (3): 172-177.
|
15. |
Voltzenlogel V, Vignal JP, Hirsch E, et al. The influence of seizure frequency on anterograde and remote memory in mesial temporal lobe epilepsy. Seizure, 2014, 23(9) : 792-798.
|
16. |
Blum D, Meador K, Biton V, et al. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy. Neurology, 2006, 67(3): 400-406.
|
17. |
Meador KJ, Loring DW, Vahle VJ, et al. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. Neurology, 2005, 64(12): 2108-2114.
|
18. |
Ristic AJ, Vojvodic N, Jankovic S, et al. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: A study of 364 patients with different types of epilepsy. Epilepsia, 2006, 47(12): 2183-2185.
|